Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Topical estradiol allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Allergy to estradiol (finding) |
Causative agent (attribute) |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Oral estradiol allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol implant allergy |
Causative agent (attribute) |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol enanthate (substance) |
Is a |
False |
Estradiol |
Inferred relationship |
Some |
|
Albumin bound estradiol (substance) |
Is a |
False |
Estradiol |
Inferred relationship |
Some |
|
Bioavailable estradiol |
Is a |
False |
Estradiol |
Inferred relationship |
Some |
|
Estradiol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 2 mg and estradiol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 2 mg and estradiol 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Albumin bound estradiol (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Estradiol |
Inferred relationship |
Some |
|
Estradiol cypionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Estradiol |
Inferred relationship |
Some |
|
Estradiol acetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Estradiol |
Inferred relationship |
Some |
|
Estradiol hemihydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Estradiol |
Inferred relationship |
Some |
|
Estradiol enanthate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Estradiol |
Inferred relationship |
Some |
|
Free estradiol |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Estradiol |
Inferred relationship |
Some |
|
Bioavailable estradiol |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Estradiol |
Inferred relationship |
Some |
|
Estradiol benzoate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Estradiol |
Inferred relationship |
Some |
|
Estradiol valerate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Estradiol |
Inferred relationship |
Some |
|
Ethinylestradiol |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Estradiol |
Inferred relationship |
Some |
|
Estradiol 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone- and estradiol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 2 mg and estradiol 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 3.125 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 3.125 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.042 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.042 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.563 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 1.563 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing estradiol and medroxyprogesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing estradiol and levonorgestrel in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol- and medroxyprogesterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing estradiol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing estradiol and norethisterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only drospirenone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing only estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing only estradiol and levonorgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol and medroxyprogesterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only estradiol and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only estradiol and norgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only dydrogesterone and estradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Estradiol and levonorgestrel only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only estradiol and medroxyprogesterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only estradiol and norethisterone in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Product containing only estradiol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing only estradiol in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol and norethisterone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
2 |
Drospirenone and estradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing only estradiol in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 312.5 nanogram/1 hour prolonged-release vaginal ring (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release vaginal ring (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 4.167 microgram/hour prolonged-release vaginal ring |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Estradiol |
Inferred relationship |
Some |
1 |
Estradiol 4.167 microgram/hour prolonged-release vaginal ring |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Estradiol |
Inferred relationship |
Some |
1 |